What is the next step in treatment for a patient with uncomplicated gonorrhea who has been on cefixime (Cefixime) 400 mg orally once daily for 3 days?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Treatment Correction Required

This patient has been incorrectly treated with cefixime for 3 days when gonorrhea requires single-dose therapy, not multi-day dosing—you must immediately stop the current regimen and administer the correct single-dose treatment: ceftriaxone 250 mg IM plus azithromycin 1 g orally. 1, 2

Critical Error in Current Management

  • Cefixime is administered as a single 400 mg oral dose, not as a multi-day course 1
  • The patient receiving cefixime for 3 consecutive days represents a fundamental misunderstanding of gonorrhea treatment protocols 2, 3
  • This incorrect dosing schedule may contribute to treatment failure and antimicrobial resistance 1

Correct Next Steps

Immediate Action Required

  • Discontinue the current incorrect cefixime regimen immediately 2
  • Administer ceftriaxone 250 mg intramuscularly as a single dose PLUS azithromycin 1 g orally as a single dose 1, 2
  • This is the CDC-recommended first-line treatment for uncomplicated gonorrhea 1, 2

Test-of-Cure Requirement

  • Schedule a test-of-cure in 1 week because the patient received an alternative (and incorrectly administered) regimen 1
  • Test-of-cure should ideally be performed with culture, or with NAAT if culture is unavailable 1
  • If culture is positive at test-of-cure, perform phenotypic antimicrobial susceptibility testing 1

If Treatment Failure Occurs

  • Treat with ceftriaxone 250 mg IM plus azithromycin 2 g orally as single doses 1
  • Obtain infectious disease consultation 1
  • Report the case to CDC through local/state health department within 24 hours 1
  • Perform culture with antimicrobial susceptibility testing 1

Why Ceftriaxone is Preferred Over Cefixime

  • Ceftriaxone 125-250 mg IM achieves 98.9-99.1% cure rates compared to cefixime's 97.4% 1, 3, 4
  • Ceftriaxone provides sustained, high bactericidal blood levels that cefixime cannot match 1, 3
  • Cefixime is only recommended when ceftriaxone is not readily available 1
  • When cefixime is used as an alternative, it must be given as a single 400 mg dose, not multiple days 1

Partner Management

  • Evaluate and treat all sexual partners from the preceding 60 days with the recommended regimen (ceftriaxone 250 mg IM plus azithromycin 1 g orally) 1
  • Consider expedited partner therapy if partners cannot be linked to timely evaluation 1

Common Pitfalls to Avoid

  • Never treat gonorrhea with multi-day courses of cefixime—this is not evidence-based and risks resistance 1, 2, 3
  • Always co-treat for chlamydia with azithromycin or doxycycline, as at least 50% of gonorrhea patients have concurrent chlamydial infection 4, 5
  • Do not use fluoroquinolones due to widespread resistance 1, 2
  • Failing to perform test-of-cure after alternative regimens can miss treatment failures 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Current Treatment for Gonorrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cefixime Cure Rate for Gonorrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of uncomplicated gonorrhea with cefotaxime.

Sexually transmitted diseases, 1981

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.